Volume 71, Number 15, October 7, 2008
About this course
- Released: 10/06/2008
- Expires: 10/07/2010
Upon completion of the article by Gronseth et al., the participant should be able to:
• Discuss how often routine neuroimaging identifies a cause of trigeminal neuralgia.
• Discuss whether there are any features that identify patients at increased risk for symptomatic trigeminal neuralgia.
• List drugs for which there is evidence for efficacy in treatment of trigeminal neuralgia.
• Discuss evidence for effectiveness of surgery for trigeminal neuralgia and discuss the complications associated with these procedures.
The article by Gronseth et al. covers the following core competencies:
• Medical Knowledge
• Practice-based Learning and Improvement
Upon completion of the article by van der Zee et al., the participant should be able to:
• Discuss the evidence presented by the authors for a clinical, pathological, and genetic spectrum of neurodegenerative brain diseases.
• Describe the implications this hypothesis holds for the molecular diagnostic testing and genetic counseling of dementia patients.
• Discuss the molecular genetics of Alzheimer disease and frontotemporal lobar degeneration.
The article by van der Zee et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
This CME program receives no commercial support.